chloroquine has been researched along with cysteamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Christensen, HN; Pisoni, RL; Thoene, JG | 1 |
| Danpure, CJ; Fyfe, DA; Jennings, PR | 1 |
| Wiskemann, A | 1 |
| Hofmann, SL; Lu, JY; Verkruyse, LA | 1 |
| Ayi, K; Bongfen, SE; Fortin, A; Gauthier, S; Gros, P; Kain, KC; Min-Oo, G; Mullick, A; Radovanovic, I; Roffê, E; Rothfuchs, AG; Santiago, H; Sher, A; Stevenson, MM; Tam, M | 1 |
1 review(s) available for chloroquine and cysteamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for chloroquine and cysteamine
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal?
Topics: Amino Acids; Biological Transport, Active; Cell Line; Chloroquine; Cysteamine; Cystinosis; Electrophoresis; Fibroblasts; Humans; Hydrogen-Ion Concentration; Lysine; Lysosomes | 1985 |
Further studies on the effect of chloroquine on the uptake, metabolism and intracellular translocation of [35S]cystine in cystinotic fibroblasts.
Topics: Biological Transport; Cells, Cultured; Chloroquine; Cysteamine; Cystine; Cystinosis; Fibroblasts; Humans; Hydrogen-Ion Concentration; Lysosomes | 1986 |
[Pharmacologic light protection].
Topics: Amino Acids; Animals; Anti-Inflammatory Agents; Chloroquine; Coloring Agents; Cysteamine; Histamine; Histidine; Humans; Mice; Phenylbutazone; Photosensitivity Disorders; Phytotherapy; Plants, Medicinal; Prednisone; Radiation-Protective Agents; Rutin; Serotonin; Tryptophan; Ultraviolet Rays | 1968 |
The effects of lysosomotropic agents on normal and INCL cells provide further evidence for the lysosomal nature of palmitoyl-protein thioesterase function.
Topics: Cell Line, Transformed; Chloroquine; Chromatography, Thin Layer; Cysteamine; Humans; Lysosomes; Neuronal Ceroid-Lipofuscinoses; Thiolester Hydrolases | 2002 |
Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium.
Topics: Amidohydrolases; Animals; Antimalarials; Candidiasis; Chagas Disease; Chloroquine; Cysteamine; Cytokines; Dose-Response Relationship, Drug; Erythrocytes; Female; GPI-Linked Proteins; Hemoglobins; Humans; Malaria; Male; Mice; Mice, Inbred C57BL; Parasitemia; Plasmodium chabaudi; Plasmodium falciparum; Trypanosoma cruzi | 2010 |